Word

NORTHX BIOLOGICS

Status

Pending

Status Code

661

Status Date

Tuesday, August 20, 2024

Serial Number

79380466

Mark Type

4

Filing Date

Monday, August 14, 2023

Trademark Owner History

NorthX Biologics AB - 1st New Owner Before Publication
NorthX Biologics Matfors AB - Original Applicant

Classifications

9 Scientific apparatus and instruments being medical laboratory research instruments for controlling, measuring, accelerating, and transporting chemicals for use in biochemical and genetic research; Scientific apparatus and instruments, namely, apparatus and instruments being medical laboratory research instruments for use in gene therapy, plasmid DNA production, cell banking and DNA sequencing

5 Pharmaceutical preparations for the supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; biological preparations for pharmaceutical purposes for the supply of and use in vaccines, cell and gene therapies, proteins, genetic biological materials; chemical preparations for pharmaceutical purposes for the supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; diagnostic preparations for pharmaceutical purposes; medicine; biological preparations for medical purposes; chemical preparations for medical purposes; diagnostic preparations for medical purposes; preparations for medical use, in particular preparations for use in gene therapy, namely, for the supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; biological reagents for medical use; advanced therapy medicinal products, namely, therapeutic pharmaceuticals for the supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; somatic cell therapy products, namely, muscle cells, blood cells, skin cells and nerve cells gene therapy products, namely, virus, viral vector, and plasmid DNA material to be used in gene therapy applications; regenerative medicine products, namely, therapeutic pharmaceuticals for the for supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; personalized medicine products, namely, therapeutic pharmaceuticals for the supply of and use in vaccines, cell and gene therapies, proteins, and genetic biological materials; cell-based preparations, namely, plasmid DNA and mRNA cell therapy productions for medical purposes; nucleic acid preparations being nucleic acid sequences for medical purposes; vaccines; recombinant proteins arrays for medical diagnosis purposes; therapeutic antibodies for medical purposes; microbial expressed protein arrays for medical diagnosis purposes; DNA vaccines; DNA plasmids being vaccines or gene therapies

1 Chemicals used in industry and science, especially proteins, enzymes and modifications thereof

42 Product research and development; new product analytical development; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; research and development for the pharmaceutical industry; biochemical research and development; research services for the development of new pharmaceutical products and advanced therapy product processes; research and development of vaccines and medicines; research and development in the field of diagnostic preparations; development of new products being biological drugs and advanced therapy product processes; medical research laboratory services; research on the subject of pharmaceuticals; provision of information and data relating to medical preparation research and development; scientific research services, and technology advisory services related to pharmaceutical research and development, development of gene therapy products, and genetic biologic products; product research and development in the field of cell banking; product research and development in the field of plasmid DNA production; product research and development in the field of DNA sequencing; medical and scientific research, namely, conducting clinical trials for others; medical and scientific research, namely, conducting clinical trials for others for pharmaceutical products; scientific and medical research on cell banks.

NORTH X BIOLOGICS
BIOLOGICS

Trademark Events

Oct 5, 2023

Sn Assigned For Sect 66a Appl From Ib

Oct 6, 2023

New Application Office Supplied Data Entered

Oct 10, 2023

Application Filing Receipt Mailed

Nov 21, 2023

Teas Change Of Owner Address Received

Nov 21, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Nov 21, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 21, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 21, 2023

Teas Change Of Domestic Representatives Address

Nov 21, 2023

Teas Change Of Correspondence Received

Apr 15, 2024

Assigned To Examiner

Apr 16, 2024

Non-Final Action Written

Apr 17, 2024

Non-Final Action (Ib Refusal) Prepared For Review

Apr 28, 2024

Non-Final Action Mailed - Refusal Sent To Ib

Apr 28, 2024

Refusal Processed By Mpu

May 22, 2024

Refusal Processed By Ib

Aug 2, 2024

Change Of Name/Address Rec'd From Ib

Aug 20, 2024

Correspondence Received In Law Office

Aug 20, 2024

Teas/Email Correspondence Entered

Aug 20, 2024

Teas Response To Office Action Received